Jci_page_head_homepage_01 Jci_page_head_homepage_02
Victor Turcanu, Soheila J. Maleki, Gideon Lack
Published in Volume 111, Issue 7
J Clin Invest. 2003; 111(7):1065–1072 doi:10.1172/JCI16142
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 1

PBMC proliferation monitored using CFSE labeling. PBMCs from a PA donor were isolated, labeled with CFSE, and cultured in the presence of 100 μg/ml peanut extract (a-c), 200 μg/ml OVA (d-f), 50 μg/ml PPD (g-i), or without exogenous antigens (j-l). On days 3, 5, and 7 after setting the cultures, cells were collected, stained with anti-CD4 PE, and analyzed by FACS. Figures represent the percentage of (CFSElow CD4+) cells included in the respective gates. Similar results were obtained in three other donors